Pharmaceutical Authority warns doctor over unapproved weight loss promotion
The Egyptian Drug Authority has warned against a doctor’s advertisement on Instagram promoting a product containing Tirzepatide as an unapproved weight loss treatment. The authority emphasized that the advertisement includes misleading claims about a product that is not registered with the Authority. The warning comes after the Authority identified advertising violations and reiterated the importance of consulting official sources before using any medication. It is important to note that while Tirzepatide is used in treatment, it is neither licensed nor registered in Egypt for this purpose, and it is sold at thousands of Egyptian pounds as a weight loss drug.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)